Naturhouse Health Past Earnings Performance
Past criteria checks 2/6
Naturhouse Health's earnings have been declining at an average annual rate of -3.1%, while the Specialty Retail industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 10.4% per year. Naturhouse Health's return on equity is 35.3%, and it has net margins of 19.5%.
Key information
-3.1%
Earnings growth rate
-3.5%
EPS growth rate
| Specialty Retail Industry Growth | 14.2% |
| Revenue growth rate | -10.4% |
| Return on equity | 35.3% |
| Net Margin | 19.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Some May Be Optimistic About Naturhouse Health's (BME:NTH) Earnings
Oct 07
We Think Naturhouse Health's (BME:NTH) Solid Earnings Are Understated
Mar 23Recent updates
Some May Be Optimistic About Naturhouse Health's (BME:NTH) Earnings
Oct 07We Think Naturhouse Health's (BME:NTH) Solid Earnings Are Understated
Mar 23Calculating The Fair Value Of Naturhouse Health, S.A. (BME:NTH)
Feb 11Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet
Oct 05What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?
Sep 22What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?
May 10Is Naturhouse Health (BME:NTH) A Risky Investment?
Mar 24Can Mixed Fundamentals Have A Negative Impact on Naturhouse Health, S.A. (BME:NTH) Current Share Price Momentum?
Mar 06A Look At The Intrinsic Value Of Naturhouse Health, S.A. (BME:NTH)
Jan 14
Would Shareholders Who Purchased Naturhouse Health's (BME:NTH) Stock Five Years Be Happy With The Share price Today?
Dec 01Revenue & Expenses Breakdown
How Naturhouse Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 50 | 10 | 13 | 0 |
| 31 Mar 24 | 50 | 11 | 13 | 0 |
| 31 Dec 23 | 50 | 11 | 13 | 0 |
| 30 Sep 23 | 50 | 11 | 13 | 0 |
| 30 Jun 23 | 51 | 10 | 14 | 0 |
| 31 Mar 23 | 51 | 10 | 14 | 0 |
| 31 Dec 22 | 52 | 10 | 15 | 0 |
| 30 Sep 22 | 54 | 11 | 15 | 0 |
| 30 Jun 22 | 56 | 12 | 15 | 0 |
| 31 Mar 22 | 58 | 13 | 15 | 0 |
| 31 Dec 21 | 58 | 13 | 15 | 0 |
| 30 Sep 21 | 57 | 13 | 18 | 0 |
| 30 Jun 21 | 59 | 14 | 15 | 0 |
| 31 Mar 21 | 53 | 10 | 15 | 0 |
| 31 Dec 20 | 55 | 9 | 16 | 0 |
| 30 Sep 20 | 60 | 9 | 21 | 0 |
| 30 Jun 20 | 64 | 9 | 23 | 0 |
| 31 Mar 20 | 77 | 12 | 26 | 0 |
| 31 Dec 19 | 82 | 13 | 27 | 0 |
| 30 Sep 19 | 83 | 13 | 30 | 0 |
| 30 Jun 19 | 83 | 13 | 30 | 0 |
| 31 Mar 19 | 85 | 15 | 31 | 0 |
| 31 Dec 18 | 87 | 15 | 31 | 0 |
| 30 Sep 18 | 88 | 16 | 31 | 0 |
| 30 Jun 18 | 91 | 17 | 31 | 0 |
| 31 Mar 18 | 93 | 18 | 31 | 0 |
| 31 Dec 17 | 95 | 20 | 30 | 0 |
| 30 Sep 17 | 96 | 21 | 29 | 0 |
| 30 Jun 17 | 98 | 22 | 29 | 0 |
| 31 Mar 17 | 98 | 22 | 29 | 0 |
| 31 Dec 16 | 98 | 23 | 28 | 0 |
| 30 Sep 16 | 98 | 23 | 27 | 0 |
| 30 Jun 16 | 98 | 23 | 27 | 0 |
| 31 Mar 16 | 96 | 23 | 27 | 0 |
| 31 Dec 15 | 96 | 23 | 27 | 0 |
| 30 Sep 15 | 96 | 23 | 27 | 0 |
| 30 Jun 15 | 96 | 23 | 27 | 0 |
| 31 Mar 15 | 96 | 23 | 27 | 0 |
| 31 Dec 14 | 96 | 23 | 26 | 0 |
| 31 Dec 13 | 60 | 9 | 19 | 0 |
Quality Earnings: NTH has high quality earnings.
Growing Profit Margin: NTH's current net profit margins (19.5%) are lower than last year (20.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NTH's earnings have declined by 3.1% per year over the past 5 years.
Accelerating Growth: NTH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NTH had negative earnings growth (-6.2%) over the past year, making it difficult to compare to the Specialty Retail industry average (0.08%).
Return on Equity
High ROE: NTH's Return on Equity (35.3%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 07:29 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Naturhouse Health, S.A. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carlos Javier Treviño Peinador | Banco Santander |
| Fernando Cordero Barreira | Banco Santander |
| Luis Esteban Arribas | Lighthouse-IEAF Servicios de Analisis |